tumor targeting

You have access
Tumor-Targeted Interleukin 2 Boosts the Anticancer Activity of FAP-Directed Radioligand Therapeutics
Andrea Galbiati, Paulina Dorten, Ettore Gilardoni, Florian Gierse, Matilde Bocci, Aureliano Zana, Jacqueline Mock, Michael Claesener, Juela Cufe, Florian Büther, Klaus Schäfers, Sven Hermann, Michael Schäfers, Dario Neri, Samuele Cazzamalli and Philipp Backhaus

Journal of Nuclear Medicine December 1, 2023, 64 (12) 1934-1940; DOI: https://doi.org/10.2967/jnumed.123.266007
You have access
Fluorescence-Guided Visualization of Soft-Tissue Sarcomas by Targeting Vascular Endothelial Growth Factor A: A Phase 1 Single-Center Clinical Trial
Pieter J. Steinkamp, Bobby K. Pranger, Mei-Fang Li, Matthijs D. Linssen, Floris J. Voskuil, Lukas B. Been, Barbara L. van Leeuwen, Albert J.H. Suurmeijer, Wouter B. Nagengast, Schelto Kruijff, Robert J. van Ginkel and Gooitzen M. van Dam

Journal of Nuclear Medicine March 1, 2021, 62 (3) 342-347; DOI: https://doi.org/10.2967/jnumed.120.245696
You have access
A ^99mTc-Labeled Ligand of Carbonic Anhydrase IX Selectively Targets Renal Cell Carcinoma In Vivo
Nikolaus Krall, Francesca Pretto, Martin Mattarella, Cristina Müller and Dario Neri

Journal of Nuclear Medicine June 1, 2016, 57 (6) 943-949; DOI: https://doi.org/10.2967/jnumed.115.170514
You have access
Radiopharmaceutical Therapy of Patients with Metastasized Melanoma with the Melanin-Binding Benzamide ¹³¹I-BA52
Walter Mier, Clemens Kratochwil, Jessica C. Hassel, Frederik L. Giesel, Barbro Beijer, John W. Babich, Matthias Friebe, Michael Eisenhut, Alexander Enk and Uwe Haberkorn

Journal of Nuclear Medicine January 1, 2014, 55 (1) 9-14; DOI: https://doi.org/10.2967/jnumed.112.112789

Main menu

User menu

Search

tumor targeting